European Pharmaceutical Review

NOVEMBER 1, 2024

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 As pharmaceutical companies are making investments in sustainable packaging this is also driving demand in this market, based on analysis of the study’s findings.

Packaging 52

Packaging Dosage Pharmaceutical Companies Pharmaceutical Companies 52

The Checkup by Singlecare

FEBRUARY 10, 2025

The pharmaceutical company Prasco currently markets a generic version of Farxiga. Additionally, several other companies have tentative FDA approvals, meaning that their generic versions have met the requirements for FDA approval but cannot yet be marketed in the United States due to patent issues.

Dosage 52

Dosage Labelling Hospitals FDA 52

The Checkup by Singlecare

MARCH 10, 2025

Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. For those licensed by the state, the deadline is April 22, 2025. For those licensed by the FDA, the deadline is May 22, 2025. A monthly supply of semaglutide ranges from about $129$1,850 without insurance.

Compounding 52

Compounding Insurance Insurance Coverage FDA 52

Pharmaceutical Technology

SEPTEMBER 22, 2022

The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. GlobalData is the parent company of Pharmaceutical Technology. per 1,000mg dosage compared to Amarin’s $4.14 at a wholesale price within the US.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA Dosage 52

The Checkup by Singlecare

SEPTEMBER 10, 2024

There have been several biosimilars approved, including Wezlana , Selarsdi, and Pyzchiva, but they are not expected to be available until early 2025. It is made by the pharmaceutical company Amgen, Inc. But Stelara is a biologic product , meaning it will have what’s called a biosimilar instead of a generic version.

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

The Thyroid Pharmacist

NOVEMBER 29, 2023

This is because I had learned about various adulterants found in supplements, how some supplement manufacturers don’t actually put the products that are on the label in the bottle, or that the dosages listed on the label may be completely different from what’s in the products. We have 270 expiring in March 2025.)

Health and Personal Care Stores 73

Health and Personal Care Stores Immunization Labelling Compounding 73

Viseven

JULY 16, 2024

Source: Deloitte Combining these types of health data allows pharmaceutical companies to understand a person’s health and genetic profile better, thereby improving the quality of healthcare products and services. Pharma companies deal with enormous amounts of health data. What Is Health Data Management?

Health and Personal Care Stores 52

Health and Personal Care Stores HIPAA Pharmaceutical Companies Pharmaceutical Companies 52